|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,336.10 INR | -0.72% |
|
-1.66% | +6.36% |
| 03/06 | Mankind Pharma Arm Acquires Remaining 10% Stake in Upakarma Ayurveda | MT |
| 22/05 | RUBBER-Japan futures extend falls on rising Chinese synthetic rubber supply | RE |
EPS & Dividend: Mankind Pharma Limited
| Fiscal Period: March | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | 4 | 6.343 | 8.117 |
| Rate of return | - | - | 0.17% | 0.27% | 0.35% |
| EPS 2 | 47.68 | 49.2 | 46.28 | 57.1 | 71.7 |
| Distribution rate | - | - | 8.94% | 11.1% | 11.3% |
| Reference price 2 | 2,300.75 | 2,424.75 | 2,336.10 | 2,336.10 | 2,336.10 |
| Nbr of stocks (in thousands) | 4,00,588 | 4,12,579 | 4,12,828 | - | - |
| Announcement Date | 15/05/24 | 21/05/25 | 19/05/26 | - | - |
1INR in Million2INR
Estimates
Past dividends: Mankind Pharma Limited
| 08/08/2025 | Ex-dividend date - 1 INR | 09:30 am |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.17% | 0.27% | 52.22x | 5.92x | 7.16x | |
| 0.6% | 0.67% | 33.11x | 19.76x | 12.04x | |
| 2.29% | 2.39% | 24.88x | 6.26x | 5.74x | |
| 3.02% | 3.18% | 27.82x | -827.16x | 6.77x | |
| 3.07% | 3.14% | 17.55x | 6.47x | 4.34x | |
| 1.8% | 1.9% | 23.42x | 5.41x | 4.85x | |
| 3.06% | 3.14% | 20.62x | 6.16x | 5.32x | |
| 4% | 3.84% | 12.56x | 5.5x | 4.71x | |
| 2.89% | 3.05% | 22.73x | 16.95x | 6.08x | |
| 2.51% | 2.57% | -46.22x | 8.77x | 5.58x | |
| Average | 2.34% | 2.42% | 18.87x | -74.60x | 6.26x | |
| Weighted average by Cap. | 2.11% | 2.19% | 22.41x | -87.22x | 7.44x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition